BRAIN Biotech AG (ETR:BNN)

Germany flag Germany · Delayed Price · Currency is EUR
2.750
+0.080 (3.00%)
Apr 29, 2026, 10:22 AM CET
17.52%
Market Cap 58.33M
Revenue (ttm) 49.01M
Net Income (ttm) -10.62M
Shares Out 21.85M
EPS (ttm) -0.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,724
Average Volume 4,535
Open 2.610
Previous Close 2.670
Day's Range 2.610 - 2.750
52-Week Range 1.805 - 3.890
Beta 0.60
RSI 61.24
Earnings Date May 28, 2026

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bio... [Read more]

Sector Materials
Founded 1993
Employees 292
Stock Exchange Deutsche Börse Xetra
Ticker Symbol BNN
Full Company Profile

Financial Performance

In fiscal year 2025, BRAIN Biotech AG's revenue was 50.22 million, a decrease of -9.52% compared to the previous year's 55.50 million. Losses were -11.74 million, 5.53% more than in 2024.

Financial Statements

News

There is no news available yet.